Caligan Partners LP's Net Worth
$0
Estimate Recalculated Sep 18, 2024 08:58PM EST
Who is Caligan Partners LP?
Caligan Partners LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., Liquidia Corp, AMAG PHARMACEUTICALS, INC., EXELIXIS, INC., and ALIMERA SCIENCES INC.
SEC CIK
Caligan Partners LP's CIK is 0001727492
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
STANDARD BIOTOOLS INC. (LAB) Snapshot price: $1.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.57% | -779.35K |
—
|
—
| 16.27M |
Jun 29 - Jul 3
| |||
Form 4
| -25.06% | -2.87M |
—
|
—
| 8.58M |
Dec 29
| |||
Form 4
| +1.35% | 301.18K |
$1.75 | $526,608.41 | 22.63M |
Aug 3 - Aug 4
| |||
Form 4
| +2.93% | 620.47K |
$1.50 | $953,649.68 | 21.8M |
Jul 29 - Aug 2
| |||
Form 4
| +0.96% | 100K |
$1.70 | $170,000.00 | 10.52M |
Jun 13
| |||
Form 4
| +2.23% | 450K |
$1.95 | $879,000.00 | 20.6M |
Jun 2 - Jun 3
| |||
Form 4
| +2.51% | 488.35K |
$2.71 | $1,406,715.00 | 19.92M |
May 6 - May 10
| |||
Form 4
| +2.20% | 400K |
$2.55 | $1,075,574.00 | 18.6M |
Apr 28 - May 2
| |||
Form 4
| +1.09% | 195K |
$3.74 | $741,150.00 | 18.12M |
Apr 11 - Apr 12
| |||
Form 4
| +3.02% | 509.57K |
$3.71 | $1,922,462.80 | 17.38M |
Apr 6 - Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Liquidia Corp (LQDA) Snapshot price: $9.2988
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.06% | 1.12M |
$8.90 | $9,999,995.50 | 8.12M |
Sep 12
| |||
Form 4
| -19.74% | -3.44M |
$9.51 |
—
| 13.99M |
Aug 30
| |||
Form 4
|
∞
| 20.36K |
—
|
—
| 20.36K |
Jun 20
| |||
Form 4
| +10.99% | 1.12M |
$7.16 | $7,999,996.88 | 11.28M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +2.41% | 250K |
$5.62 | $1,405,000.00 | 10.64M |
Sep 6
| |||
Form 4
| +0.77% | 79.4K |
$3.40 | $269,960.00 | 10.39M |
May 25
| |||
Form 4
| +1.09% | 221.1K |
$5.92 | $1,301,472.56 | 20.47M |
May 17 - May 19
| |||
Form 4
| +21.19% | 1.76M |
$5.10 | $8,999,995.50 | 10.09M |
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.50M |
—
|
—
|
0
|
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +38.61% | 425K |
$20.55 | $8,733,955.00 | 1.53M |
May 28 - May 30
| |||
Form 4
| +20.86% | 190K |
$20.70 | $3,932,734.00 | 1.1M |
Feb 21
| |||
Form 4
|
—
|
0
|
$21.61 |
—
| 910.73K |
Nov 27
| |||
Form 4
|
∞
| 18.18K |
—
|
—
| 18.18K |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALIMERA SCIENCES INC (ALIM) Snapshot price: $5.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.84M |
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
$3.39 |
—
| 33.09M |
Sep 14
| |||
Form 4
| +421.30% | 16.36M |
$1.90 | $28,975,745.30 | 20.24M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||